Loss of PTPRK in hepatocytes reduces steatosis and carcinogen-induced tumour development in obesity

Authors:

Abstract
Protein tyrosine phosphatases are crucial regulators of metabolism with specific roles in different tissues. To investigate hepatocyte-specific function of protein tyrosine phosphatase receptor type K (PTPRK), we generated mice carrying floxed Ptprk alleles and crossed them with Alb-Cre mice ( Ptprk ΔHep mice). Under chow feeding, Ptprk ΔHep mice were largely comparable to littermate controls. In contrast, Ptprk ΔHep mice fed a high-fat, high-fructose, high-cholesterol diet exhibited reduced steatosis, lower hepatic PPARγ, and blunted hepatocyte hypertrophy, accompanied by improved systemic insulin sensitivity, as assessed by hyperinsulinemic-euglycemic clamps. We identified PTPRK-interacting proteins enriched for metabolic functions associated with glycolysis and lipid biosynthesis using pull downs from primary hepatocyte lysates. In line with these findings, Ptprk ΔHep mice developed fewer tumours than controls in an obesity and carcinogen-induced hepatocellular carcinoma (HCC) model. Our data show that under nutrient excess PTPRK is functionally engaged in hepatocytes to support PPARγ-linked steatotic growth, insulin resistance, and tumour initiation, highlighting PTPRK as a potential therapeutic target in MASLD-associated HCC.
Funding Information
  • European Research Council (GA817940)
  • FNRS (40020272)
  • FNRS (40007402)
  • FNRS (40018756)
  • FNRS (40025595)
  • Fonds Paul GENICOT
  • The ULB Foundation
  • Department of Biotechnology

This publication has 34 references indexed in Scilit: